Work

An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder

Year: 2026

Type: article

Study design: Clinical Trial

Source: Clinical Neuropharmacology

DOI: 10.1097/wnf.0000000000000683

Authors: Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan

Institution: University of Chicago

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154114794

FWCI:

Cites: 32

Cited by:

Related to: